The Effect of UrsodeoXyCholicacid (UDCA) and ezetimibe on total faecal steRol ExcreTion and plasma lipid lEvels

Registry ID

EUCTR2016-003281-84

Source registry

EUCTR

Status

Ongoing

Phase

PHASE4

Sponsor

Academical Medical Centre, department of internal

Start date

2018-03-27

Last update

2026-08-16

Conditions

• Familial hypercholesterolemia

Summary

The primary objective is to evaluate the effect of UDCA and ezetimibe on cholesterol elimination assessed as total faecal sterol concentration.

Locations

• , , Netherlands

View on source registry